These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22386978)

  • 1. C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.
    Kumar KS; Kiran Kumar S; Yogi Sreenivas B; Gorja DR; Kapavarapu R; Rambabu D; Rama Krishna G; Reddy CM; Basaveswara Rao MV; Parsa KV; Pal M
    Bioorg Med Chem; 2012 Apr; 20(7):2199-207. PubMed ID: 22386978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pd-mediated functionalization of polysubstituted pyrroles: their evaluation as potential inhibitors of PDE4.
    Bhaskar Kumar T; Sumanth Ch; Vaishaly S; Srinivasa Rao M; Chandra Sekhar KB; Meda CL; Kandale A; Rambabu D; Rama Krishna G; Malla Reddy C; Shiva Kumar K; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5639-47. PubMed ID: 22871579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montmorillonite K-10 mediated green synthesis of cyano pyridines: Their evaluation as potential inhibitors of PDE4.
    Ram Reddy T; Rajeshwar Reddy G; Srinivasula Reddy L; Jammula S; Lingappa Y; Kapavarapu R; Meda CL; Parsa KV; Pal M
    Eur J Med Chem; 2012 Feb; 48():265-74. PubMed ID: 22217868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 4-alkynyl pyrazoles as inhibitors of PDE4: a practical access via Pd/C-Cu catalysis.
    Gorja DR; Shiva Kumar K; Kandale A; Meda CL; Parsa KV; Mukkanti K; Pal M
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2480-7. PubMed ID: 22381049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of oxazole-based PDE4 inhibitors with picomolar potency.
    Kuang R; Shue HJ; Xiao L; Blythin DJ; Shih NY; Chen X; Gu D; Schwerdt J; Lin L; Ting PC; Cao J; Aslanian R; Piwinski JJ; Prelusky D; Wu P; Zhang J; Zhang X; Celly CS; Billah M; Wang P
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2594-7. PubMed ID: 22401864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a six-membered fused N-heterocyclic ring via a new 3-component reaction: synthesis of (pyrazolo)pyrimidines/pyridines.
    Kumar PM; Kumar KS; Mohakhud PK; Mukkanti K; Kapavarapu R; Parsa KV; Pal M
    Chem Commun (Camb); 2012 Jan; 48(3):431-3. PubMed ID: 22075973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally restricted novel pyrazole derivatives: synthesis of 1,8-disubstituted 5,5-dimethyl-4,5-dihydro-1H-benzo[g]indazoles as a new class of PDE4 inhibitors.
    Reddy TS; Kumar KS; Meda CL; Kandale A; Rambabu D; Krishna GR; Hariprasad C; Rao VV; Venkataiah S; Reddy CM; Naidu A; Dubey PK; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2012 May; 22(9):3248-55. PubMed ID: 22464134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 1-alkynyl substituted 1,2-dihydroquinoline derivatives from nimesulide (and their 2-oxo analogues): a new strategy to identify inhibitors of PDE4B.
    Pal S; Durgadas S; Nallapati SB; Mukkanti K; Kapavarapu R; Meda CL; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6573-6. PubMed ID: 21920740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells.
    Mareddy J; Nallapati SB; Anireddy J; Devi YP; Mangamoori LN; Kapavarapu R; Pal S
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6721-7. PubMed ID: 24215890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montmorillonite K-10 catalyzed green synthesis of 2,6-unsubstituted dihydropyridines as potential inhibitors of PDE4.
    Reddy TR; Reddy GR; Reddy LS; Meda CL; Parsa KV; Kumar KS; Lingappa Y; Pal M
    Eur J Med Chem; 2013 Apr; 62():395-404. PubMed ID: 23380174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of oral and inhaled PDE4 inhibitors.
    Ting PC; Lee JF; Kuang R; Cao J; Gu D; Huang Y; Liu Z; Aslanian RG; Feng KI; Prelusky D; Lamca J; House A; Phillips JE; Wang P; Wu P; Lundell D; Chapman RW; Celly CS
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5528-32. PubMed ID: 24018187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiophene inhibitors of PDE4: crystal structures show a second binding mode at the catalytic domain of PDE4D2.
    Nankervis JL; Feil SC; Hancock NC; Zheng Z; Ng HL; Morton CJ; Holien JK; Ho PW; Frazzetto MM; Jennings IG; Manallack DT; Martin TJ; Thompson PE; Parker MW
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7089-93. PubMed ID: 22030030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of triazines as potent, selective and orally active PDE4 inhibitors.
    Gewald R; Grunwald C; Egerland U
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4308-14. PubMed ID: 23806553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound mediated catalyst free synthesis of 6H-1-benzopyrano[4,3-b]quinolin-6-ones leading to novel quinoline derivatives: their evaluation as potential anti-cancer agents.
    Mulakayala N; Rambabu D; Raja MR; M C; Kumar CS; Kalle AM; Rama Krishna G; Malla Reddy C; Basaveswara Rao MV; Pal M
    Bioorg Med Chem; 2012 Jan; 20(2):759-68. PubMed ID: 22202437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
    Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
    Taltavull J; Serrat J; Gràcia J; Gavaldà A; Córdoba M; Calama E; Montero JL; Andrés M; Miralpeix M; Vilella D; Hernández B; Beleta J; Ryder H; Pagès L
    Eur J Med Chem; 2011 Oct; 46(10):4946-56. PubMed ID: 21871695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 2,2,4-trimethyl-1,2-dihydroquinolinyl substituted 1,2,3-triazole derivatives: their evaluation as potential PDE 4B inhibitors possessing cytotoxic properties against cancer cells.
    Praveena KS; Durgadas S; Suresh Babu N; Akkenapally S; Ganesh Kumar C; Deora GS; Murthy NY; Mukkanti K; Pal S
    Bioorg Chem; 2014 Apr; 53():8-14. PubMed ID: 24463218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A direct access to 3-(2-Oxoalkyl)indoles via aluminum chloride induced C-C bond formation.
    Pal M; Dakarapu R; Padakanti S
    J Org Chem; 2004 Apr; 69(8):2913-6. PubMed ID: 15074955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration.
    Woodrow MD; Ballantine SP; Barker MD; Clarke BJ; Dawson J; Dean TW; Delves CJ; Evans B; Gough SL; Guntrip SB; Holman S; Holmes DS; Kranz M; Lindvaal MK; Lucas FS; Neu M; Ranshaw LE; Solanke YE; Somers DO; Ward P; Wiseman JO
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5261-5. PubMed ID: 19656678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
    Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
    Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.